1. Home
  2. MS vs ABT Comparison

MS vs ABT Comparison

Compare MS & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley

MS

Morgan Stanley

HOLD

Current Price

$165.59

Market Cap

255.2B

Sector

Finance

ML Signal

HOLD

ABT

Abbott Laboratories

HOLD

Current Price

$102.78

Market Cap

183.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MS
ABT
Founded
1924
1888
Country
United States
United States
Employees
83000
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.2B
183.3B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
MS
ABT
Price
$165.59
$102.78
Analyst Decision
Buy
Strong Buy
Analyst Count
15
17
Target Price
$178.00
$137.71
AVG Volume (30 Days)
5.6M
7.2M
Earning Date
04-15-2026
04-16-2026
Dividend Yield
2.41%
2.46%
EPS Growth
N/A
N/A
EPS
N/A
3.72
Revenue
N/A
$44,328,000,000.00
Revenue This Year
$12.09
$8.90
Revenue Next Year
$5.39
$7.39
P/E Ratio
$17.30
$27.53
Revenue Growth
N/A
5.67
52 Week Low
$94.33
$100.88
52 Week High
$192.68
$137.49

Technical Indicators

Market Signals
Indicator
MS
ABT
Relative Strength Index (RSI) 51.99 32.79
Support Level $154.82 N/A
Resistance Level $165.96 $112.81
Average True Range (ATR) 4.59 2.16
MACD 1.19 -0.30
Stochastic Oscillator 73.93 17.07

Price Performance

Historical Comparison
MS
ABT

About MS Morgan Stanley

Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Share on Social Networks: